Health
New target for drug development could fill a major gap in depression treatment – News-Medical.net
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects.
THE IDEA
Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression.
The research was led by Lisa Monteggia,…
Continue Reading
-
General22 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News23 hours agoPolice appeal for information after two men found dead
-
General23 hours agoTariff letters to 12 countries going out Monday: Trump
-
General23 hours agoCan the world be governed without the US? • Inside Story